| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1089-3261(03)00103-X |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S108932610300103X?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:S108932610300103X?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 14594138 |
| P5875 | ResearchGate publication ID | 9029855 |
| P2093 | author name string | Robert L. Carithers | |
| P2860 | cites work | A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 |
| Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis | Q33745849 | ||
| URSO-panacea or placebo? | Q33873354 | ||
| Rationale for trials of long-term mycophenolate mofetil therapy for primary biliary cirrhosis | Q34516425 | ||
| Is copper hepatotoxic in primary biliary cirrhosis? | Q39373939 | ||
| Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis | Q40883127 | ||
| A prospective trial of colchicine for primary biliary cirrhosis | Q42659809 | ||
| Ursodeooxycholic acid for primary biliary cirrhosis | Q43561664 | ||
| Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past--issues for the future | Q43623767 | ||
| Ursodeoxycholic acid for primary biliary cirrhosis: lesson for the future? | Q43659683 | ||
| Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients. | Q43734578 | ||
| Randomized trial of chlorambucil for primary biliary cirrhosis. | Q44093311 | ||
| Prognosis in primary biliary cirrhosis: model for decision making | Q46316848 | ||
| Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis? | Q49100848 | ||
| Ursodeoxycholic acid in primary biliary cirrhosis. | Q53597888 | ||
| Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid. | Q54032405 | ||
| Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. | Q54118475 | ||
| Long-term follow-up of patients with primary biliary cirrhosis on colchicine therapy. | Q55052049 | ||
| A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results | Q67590480 | ||
| Evaluation of colchicine therapy in primary biliary cirrhosis | Q68139571 | ||
| A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis | Q68505504 | ||
| A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report | Q69401293 | ||
| A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss | Q69721905 | ||
| Trial of penicillamine in advanced primary biliary cirrhosis | Q69887093 | ||
| A prospective trial of D-penicillamine in primary biliary cirrhosis | Q70210395 | ||
| Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial | Q70542319 | ||
| The results of a randomized double blind controlled trial evaluating malotilate in primary biliary cirrhosis. A European multicentre study group | Q70590270 | ||
| Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis | Q71035932 | ||
| Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: a prospective randomized study | Q71598528 | ||
| Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis | Q71605603 | ||
| The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study | Q71739390 | ||
| A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group | Q71748735 | ||
| Effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirrhosis | Q71807572 | ||
| Interstitial pneumonitis after low-dose methotrexate therapy in primary biliary cirrhosis | Q72036049 | ||
| A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid | Q72189521 | ||
| Ursodeoxycholic acid in the treatment of primary biliary cirrhosis | Q72401649 | ||
| D-penicillamine treatment improves survival in primary biliary cirrhosis | Q72471832 | ||
| Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial | Q73026352 | ||
| A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis | Q73118377 | ||
| Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment | Q73316077 | ||
| Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid | Q73401694 | ||
| The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone | Q73574823 | ||
| Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines | Q73584928 | ||
| Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver | Q73715566 | ||
| Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study | Q77619532 | ||
| Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol | Q78039881 | ||
| Low-dose methotrexate is ineffective in primary biliary cirrhosis: long-term results of a placebo-controlled trial | Q78039888 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | primary biliary cholangitis | Q1072420 |
| clinical trial | Q30612 | ||
| P304 | page(s) | 923-939 | |
| P577 | publication date | 2003-11-01 | |
| P1433 | published in | Clinics in liver disease | Q26842322 |
| P1476 | title | Primary biliary cirrhosis: specific treatment | |
| P478 | volume | 7 |
| Q36407314 | Basic immunosuppressive drugs outside solid organ transplantation |
| Q33866454 | Concept on the pathogenesis and treatment of primary biliary cirrhosis |
| Q46521938 | Cost and health consequences of treatment of primary biliary cirrhosis with ursodeoxycholic acid |
| Q24243989 | Cyclosporin A for primary biliary cirrhosis |
| Q79854104 | Trials in primary biliary cirrhosis: need for the right drugs at the right time |
Search more.